JCR Japan College of Rheumatology-
有限責任中間法人 日本リウマチ学会
 
 

トップページ
バックナンバー
学会誌MR
NLリウマチ
メルマガ
旧和文誌
会員へのお知らせ
医療・医薬情報
リウマチ学会TV
住所・勤務先変更

MODERN RHEUMATOLOGY Vol.16 No.1

Vol.16 No.1 に戻る


CASE REPORT

A case of interstitial pneumonia caused by bucillamine: a study using serological markers

Full Text (PDF)

Kazuhide Tanimura1 , Masato Shimizu1, Megumi Matsuhashi1, Masahide Shinohara1 and Akira Sagawa1

(1) Rheumatic and Collagen Disease Center, Sapporo Yamanoue Hospital, 6-9-1-1 Yamanote, Nishi-ku, Sapporo 063-0006, Japan

Received: 29 June 2005 Accepted: 17 October 2005

Abstract The patient was a 61-year-old man diagnosed with rheumatoid arthritis (RA) in 2001. He initially received treatment at a nearby clinic, but his condition could not be satisfactorily controlled. He subsequently consulted our hospital during the same year. Although his symptoms improved in response to treatment at our hospital, slight fever, cough, and then high fever and dyspnea subsequently developed. A diagnosis of interstitial pneumonia was made on the basis of findings of diagnostic imaging. The time course of changes in serological markers, including surfactant protein A (SP-A), surfactant protein D (SP-D), and KL-6, as well as markers of inflammatory reaction and lactate dehydrogenase was examined to determine the clinical significance of serological markers in the management of interstitial pneumonia.

Key words Bucillamine - Interstitial pneumonia - KL-6 - Surfactant protein A (SP-A) - Surfactant protein D (SP-D)


The references of this article are secured to subscribers.



Copyright Japan College of Rheumatology All rights reserved.